The compound has been researched while in the patent literature for its anxiolytic properties and reduced sedative, hypnotic, and ataxic side-effects, but it doesn't seem like licensed for healthcare use. Łukasik-Głebocka et alBenzo derivatives, including Flubromazolam, produce the exact same effects although avoiding all legal and production reg